Acute Lymphoblastic Leukemia in Adults

Our pathologists, hematologists, and oncologists combine their expertise to determine the genetic characteristics of acute lymphoblastic leukemia, a fast-growing cancer of the blood and bone marrow. Together, we accurately diagnose the condition and create a personalized treatment plan, which may include chemotherapy, targeted medications, or stem cell transplantation. Throughout the treatment process and beyond, we provide supportive services to you and your loved ones.

Clinical Trials and Research Studies

Phase 1/2

AN OPEN-LABEL MULTICENTER PHASE l/1B TRIAL EVALUATING THE SAFETY ANDPHARMACOKINETICS OF ESCALATING DOSES OF BTCT4465A AS A SINGLE AGENT ANDCOMBINED WITH ATEZOLIZUMAB IN PATIENTS WITH RELAPSED OR REFRACTORYB-CELL NON-HODGKIN S LYMPHOMA AND CHRONIC LYMPHOCYTIC LEUKEMIA

Learn More

Phase 1/2

A Phase Ib/IIa Study Evaluating the Safety and Tolerability of Vitamin C in Patients with Intermediate or high Risk Myelodysplastic Syndrome with TET2 Mutations

Learn More

Phase 2

AALL1621: A Phase 2 Study of Inotuzumab Ozogamicin (NSC# 772518 IND#133494) in Children and Young Adults with Relapsed or Refractory CD22+ B-Acute Lymphoblastic Leukemia (B-ALL)

Learn More

Phase N/A

AALL15P1 A Groupwide Pilot Study to Test the Tolerability and Biologic Activity of the Addition of Azacitidine (IND# 133688 NSC# 102816) to Chemotherapy in Infants with Acute Lymphoblastic Leukemia (ALL) and KMT2A (MLL) Gene Rearrangement

Learn More